Status | Study |
Not yet recruiting |
Study Name: Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice Condition: Active Non-infectious Intermediate, Posterior and Panuveitis Date: 2017-05-15 |
Recruiting |
Study Name: HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis Condition: Uveitis Date: 2016-09-14 |
Active, not recruiting |
Study Name: A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye Condition: Posterior Uveitis Intermediate Uveitis Date: 2016-04-19 Interventions: Drug: FAI insert |
Active, not recruiting |
Study Name: Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis Condition: Posterior Uveitis Intermediate Uveitis Date: 2016-04-19 Interventions: Drug: Sham Injection Drug: FAI Insert |
Recruiting |
Study Name: Ocular Sarcoidosis Open Label Trial of ACTHAR Gel Condition: Ocular Sarcoidosis Panuveitis Date: 2016-03-11 Interventions: Drug: Repository Corticotropin Injection |
Withdrawn |
Study Name: Study of FTY720 in Patients With Uveitis Condition: Acute Noninfectious Posterior, Intermediate, or Pan Uveitis Date: 2013-02-12 Interventions: Drug: FTY720 Fingolimod |
Active, not recruiting |
Study Name: Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis Condition: Uveitis Affecting the Posterior Segment Date: 2012-12-04 Interventions: Drug: Fluocinolone Acetonide |
Active, not recruiting |
Study Name: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Condition: Intermediate Uveitis Posterior Uveitis Date: 2012-10-26 Interventions: Drug: Tocilizumab Tocilizumab (4 mg/kg or 8 mg/kg) O |
Active, not recruiting |
Study Name: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Condition: Posterior Uveitis Intermediate Uveitis Date: 2012-09-24 Interventions: Drug: FAI insert Drug: Sham injection |
Terminated |
Study Name: Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Condition: Uveitis Date: 2012-09-10 Interventions: Drug: Placebo Solution for sub |